INHIBITION OF MYCOLIC ACID TRANSPORT ACROSS THE MYCOBACTERIUM TUBERCULOSIS PLASMA MEMBRANE

New chemotherapeutics active against multidrug-resistant Mycobacterium tuberculosis (M. tb) are urgently needed. We report on the identification of an adamantyl urea compound displaying potent bactericidal activity against M. tb and a unique mode of action, namely the abolition of the translocation of mycolic acids from the cytoplasm where they are synthesized to the periplasmic side of the plasma membrane where they are transferred onto cell wall arabinogalactan or used in the formation of virulence-associated outer membrane trehalose-containing glycolipids. Whole genome sequencing of spontaneous resistant mutants of M. tb selected in vitro followed by genetic validation experiments revealed that our prototype inhibitor targets the inner membrane transporter, MmpL3. Conditional gene expression of mmpL3 in mycobacteria and analysis of inhibitor-treated cells validate MmpL3 as essential for mycobacterial growth and support the involvement of this transporter in the translocation of trehalose monomycolate across the plasma membrane.

[1]  C. Briand,et al.  Crystal structure of the multidrug exporter MexB from Pseudomonas aeruginosa. , 2009, Journal of molecular biology.

[2]  J. Cox,et al.  Interaction between Polyketide Synthase and Transporter Suggests Coupled Synthesis and Export of Virulence Lipid in M. tuberculosis , 2005, PLoS pathogens.

[3]  Spencer J. Williams,et al.  Compartmentalization of Lipid Biosynthesis in Mycobacteria* , 2005, Journal of Biological Chemistry.

[4]  B. Gicquel,et al.  Gene Replacement and Transposon Delivery Using the Negative Selection Marker sacB. , 2001, Methods in molecular medicine.

[5]  R. Slayden,et al.  Mycolic acids: structure, biosynthesis and physiological functions. , 1998, Progress in lipid research.

[6]  Gilla Kaplan,et al.  The Role of MmpL8 in Sulfatide Biogenesis and Virulence of Mycobacterium tuberculosis* , 2004, Journal of Biological Chemistry.

[7]  M. Braunstein,et al.  Silencing Essential Protein Secretion in Mycobacterium smegmatis by Using Tetracycline Repressors , 2007 .

[8]  L. Armitige,et al.  Evidence for a partial redundancy of the fibronectin‐binding proteins for the transfer of mycoloyl residues onto the cell wall arabinogalactan termini of Mycobacterium tuberculosis , 2002, Molecular microbiology.

[9]  G. De Libero,et al.  Diacylated Sulfoglycolipids Are Novel Mycobacterial Antigens Stimulating CD1-restricted T Cells during Infection with Mycobacterium tuberculosis , 2004, The Journal of experimental medicine.

[10]  M. Glickman.  5 Cording, Cord Factors, and Trehalose Dimycolate , 2008 .

[11]  M. Voskuil,et al.  The Mycobacterium tuberculosis DosR Regulon Assists in Metabolic Homeostasis and Enables Rapid Recovery from Nonrespiring Dormancy , 2009, Journal of bacteriology.

[12]  G. Besra,et al.  Identification of the apparent carrier in mycolic acid synthesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Mohamed Chami,et al.  Direct Visualization of the Outer Membrane of Mycobacteria and Corynebacteria in Their Native State , 2008, Journal of bacteriology.

[14]  J. Grooten,et al.  Molecular structure of the Mycobacterium tuberculosis virulence factor, mycolic acid, determines the elicited inflammatory pattern , 2011, European journal of immunology.

[15]  D. Ronning,et al.  Antigen 85C-mediated acyl-transfer between synthetic acyl donors and fragments of the arabinan , 2009, Glycoconjugate Journal.

[16]  Brigitte Gicquel,et al.  Definition of the First Mannosylation Step in Phosphatidylinositol Mannoside Synthesis , 2002, The Journal of Biological Chemistry.

[17]  Spencer J. Williams,et al.  Trehalose Is Required for Growth of Mycobacterium smegmatis* , 2004, Journal of Biological Chemistry.

[18]  Andrew Leis,et al.  Disclosure of the mycobacterial outer membrane: Cryo-electron tomography and vitreous sections reveal the lipid bilayer structure , 2008, Proceedings of the National Academy of Sciences.

[19]  S. Murakami,et al.  Multidrug efflux transporter, AcrB--the pumping mechanism. , 2008, Current opinion in structural biology.

[20]  G. Besra,et al.  Biogenesis of the mycobacterial cell wall and the site of action of ethambutol , 1995, Antimicrobial agents and chemotherapy.

[21]  D. Crick,et al.  Targeting the formation of the cell wall core of M. tuberculosis. , 2007, Infectious disorders drug targets.

[22]  D. Schomburg,et al.  The Crucial Role of Trehalose and Structurally Related Oligosaccharides in the Biosynthesis and Transfer of Mycolic Acids in Corynebacterineae* , 2005, Journal of Biological Chemistry.

[23]  B. Gicquel,et al.  Virulence attenuation of two Mas-like polyketide synthase mutants of Mycobacterium tuberculosis. , 2003, Microbiology.

[24]  D. Minnikin,et al.  Loss of a Mycobacterial Gene Encoding a Reductase Leads to an Altered Cell Wall Containing β-oxo- Mycolic Acid Analogs and Accumulation of Ketones , 2008, Chemistry & biology.

[25]  M. Reed,et al.  Contribution of the Mycobacterium tuberculosis MmpL Protein Family to Virulence and Drug Resistance , 2005, Infection and Immunity.

[26]  E. J. North,et al.  The structure-activity relationship of urea derivatives as anti-tuberculosis agents. , 2011, Bioorganic & medicinal chemistry.

[27]  G. Besra,et al.  Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. , 1997, Science.

[28]  M H Saier,et al.  Phylogeny of multidrug transporters. , 2001, Seminars in cell & developmental biology.

[29]  R. Coppel,et al.  The Reductase That Catalyzes Mycolic Motif Synthesis Is Required for Efficient Attachment of Mycolic Acids to Arabinogalactan* , 2007, Journal of Biological Chemistry.

[30]  B. Gicquel,et al.  Long-chain multiple methyl-branched fatty acid-containing lipids of Mycobacterium tuberculosis: biosynthesis, transport, regulation and biological activities. , 2007, Tuberculosis.

[31]  Angelina Iniguez,et al.  Discovery and characterization of a unique mycobacterial heme acquisition system , 2011, Proceedings of the National Academy of Sciences.

[32]  B. Gicquel,et al.  p-Hydroxybenzoic Acid Synthesis in Mycobacterium tuberculosis* , 2005, Journal of Biological Chemistry.

[33]  K. Takayama,et al.  Purification and characterization of a novel mycolic acid exchange enzyme from Mycobacterium smegmatis. , 1987, The Journal of biological chemistry.

[34]  O. Burlet-Schiltz,et al.  The Pks13/FadD32 Crosstalk for the Biosynthesis of Mycolic Acids in Mycobacterium tuberculosis* , 2009, The Journal of Biological Chemistry.

[35]  M. Daffé,et al.  The envelope layers of mycobacteria with reference to their pathogenicity. , 1998, Advances in microbial physiology.

[36]  J. Belisle,et al.  Lipidomic analyses of Mycobacterium tuberculosis based on accurate mass measurements and the novel “Mtb LipidDB”[S] , 2011, Journal of Lipid Research.

[37]  William R. Jacobs,et al.  Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice , 1999, Nature.

[38]  B. Gicquel,et al.  Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope , 1999, Molecular microbiology.

[39]  Brian D Robertson,et al.  The OtsAB Pathway Is Essential for Trehalose Biosynthesis in Mycobacterium tuberculosis* , 2005, Journal of Biological Chemistry.

[40]  S T Cole,et al.  Analysis of the proteome of Mycobacterium tuberculosis in silico. , 1999, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[41]  I. Smith,et al.  Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice , 2000, Molecular microbiology.

[42]  G. Besra,et al.  Trehalose-recycling ABC transporter LpqY-SugA-SugB-SugC is essential for virulence of Mycobacterium tuberculosis , 2010, Proceedings of the National Academy of Sciences.

[43]  G. Besra,et al.  Pathway to Synthesis and Processing of Mycolic Acids in Mycobacterium tuberculosis , 2005, Clinical Microbiology Reviews.

[44]  J. Aínsa,et al.  Role of mycobacterial efflux transporters in drug resistance: an unresolved question. , 2006, FEMS microbiology reviews.

[45]  Luiz Augusto Basso,et al.  Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis. , 2002, Current pharmaceutical biotechnology.

[46]  E. Chow,et al.  12 The MmpL Protein Family , 2008 .

[47]  B. Gicquel,et al.  Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. , 2001, The Journal of biological chemistry.

[48]  Carolyn R Bertozzi,et al.  MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[49]  G. Besra,et al.  Thiacetazone, an Antitubercular Drug that Inhibits Cyclopropanation of Cell Wall Mycolic Acids in Mycobacteria , 2007, PloS one.

[50]  B. Hammock,et al.  Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. , 2005, Annual review of pharmacology and toxicology.